SAN Sanofi

69.96EUR-0.04%Mkt Cap: 91.14B $P/E: 21.54

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelit…

Key Statistics

Company
Market Cap91.14B USD
Enterprise Value111.33B USD
Revenue (TTM)53.17B USD
Gross Profit36.59B USD
Net Income (TTM)8.49B USD
Revenue/Share40.50 EUR
Last Price69.96 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees74.8K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000120578
Valuation
P/E (Trailing)21.54
P/E (Forward)7.79
PEG27.37
EV/EBITDA7.56
EV/Revenue2.09
P/S1.73
P/B1.23
EPS (TTM)3.25
EPS (Forward)9.09
52W Range
69.751% of range91.15
52W High91.15 EUR
52W Low69.75 EUR
Profitability
Gross Margin72.07%
Oper. Margin21.03%
EBITDA Margin27.68%
Profit Margin16.72%
ROE10.95%
ROA6.16%
Growth
Revenue Growth14.60%
Earnings Growth-91.20%
Cash Flow & Leverage
Operating CF11.68B USD
CapEx (TTM)3.85B USD
FCF Margin12.88%
FCF Yield7.51%
Net Debt18.72B USD
Net Debt/EBITDA1.27
Balance Sheet
Debt/Equity0.28
Current Ratio0.99
Quick Ratio0.49
Book Value/Sh57.77 EUR
Cash/Share5.30 EUR
Dividends
Fwd Div Rate4.12 EUR
Trail. Div Rate4.12 EUR
Div. Yield5.82%
5Y Avg Yield4.00%
Payout Ratio126.68%
Ex-Div DateMay 5, 2026
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)94.06 EUR
Upside (mean)+34.4%
Target Range78.00 EUR – 112.00 EUR
78.00+34.4% to mean112.00
# Analysts24
Ownership
Shares Out.1.20B
Float1.08B
Insiders10.31%
Institutions42.33%
Technical
SMA 5075.38 (-7.2%)
SMA 20077.50 (-9.7%)
Beta0.28
S&P 52W Chg14.58%
Avg Vol (30d)2.01M
Avg Vol (10d)2.35M
Technical Indicators
RSI (14)32.8
MACD-1.2502
MACD Signal-1.0011
MACD Hist.-0.2491
BB Upper76.26 EUR
BB Middle73.25 EUR
BB Lower70.24 EUR
BB Width8.22%
ATR (14)1.630 EUR
Vol Ratio (20d)0.88x